Arrhythmias & electrophysiology
Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: the PRO-PVI study
An erratum to this article was published (Europace, 19 May 2023 ↗)
Authors' conclusion
The use of the closure device for femoral venous access after PVI led to safe discharge of patients within 6 h from the intervention in 96% of the population.
Study context
- Population
- Patients scheduled for pulmonary vein isolation (PVI)
- Participants
- 50 patients
- Exposure
- Perclose Proglide suture-mediated closure in ambulatory PVI vs usual workflow (matched cohort)
- Perclose Progliden = 50
- Outcome
- Feasibility: % discharged the day of procedure
Methodological detailspropensity-matched control cohort (1:1)
- Propensity-matched control cohort (1:1)
Main finding
As reported in the abstract
Same-day discharge
Perclose Proglide
96%
Observational data: associations, not effects.
Further findings
Device deployment success
- Devices successfully deployed
- 100%
Immediate (<1 min) haemostasis
- Patients reaching immediate (<1 min) haemostasis
- 30 (62.5%)
Patient satisfaction with post-operative time
- High level of satisfaction reported
Cost
- Neutral cost impact vs standard of care
Safety
Major vascular complications · 30 days
- No major vascular complication occurred
Original publication
Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: the PRO-PVI study. Europace. Published 16 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →